[Virtual CME/CPE] Unlocking the potential of Fondaparinux

  • 1 Cat 1B CME point will be awarded for Doctors (submitted by organizer).
  • 1 Cat 1A CPE point will be awarded for Pharmacists (self-claimed by pharmacists).
  • 1 Cat II-B CPE point will be awarded for Nurses (self-claimed by nurses) – please use the Zoom attendance email to submit as proof as attendance

Date and Time:
Thursday, 16 October 2025 | 1:00PM – 2:00PM SGT

Venue:
Online (Zoom Platform)

This session will cover Fondaparinux in anticoagulation, its advantages in managing Heparin-Induced Thrombocytopenia (HIT), lower bleeding risk, and its role in Acute Coronary Syndrome (ACS) guidelines. We will also explore the recent 2025 meta-analysis, offering updated evidence on outcomes and safety, with practical insights for real-world application.

You must be healthcare professional to view this content.

POMConnect Banner2 Email Bottom